Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Randomized, Double-blind, Sham Surgery-controlled Study of the Efficacy and Safety of Intraputaminal AAV2-GDNF in the Treatment of Adults With Moderate Stage Parkinson's Disease

NCT06285643 is registered in ClinicalTrials.gov with AskBio Inc as lead sponsor.

NCT NCT06285643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06285643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Randomized, Double-blind, Sham Surgery-controlled Study of the Efficacy and Safety of Intraputaminal AAV2-GDNF in the Treatment of Adults With Moderate Stage Parkinson's Disease
Lead sponsor
AskBio Inc
Phase
Phase 2
Overall status
Active, not recruiting
Start date
June 11, 2024
Completion date
August 31, 2028
Enrollment
127 (estimated)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease